3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole has been researched along with lobeline in 1 studies
Studies (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole) | Trials (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole) | Recent Studies (post-2010) (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole) | Studies (lobeline) | Trials (lobeline) | Recent Studies (post-2010) (lobeline) |
---|---|---|---|---|---|
68 | 2 | 18 | 495 | 20 | 68 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Holley, LA; Sarter, M; Turchi, J | 1 |
1 other study(ies) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and lobeline
Article | Year |
---|---|
Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats.
Topics: Animals; Anti-Anxiety Agents; Arousal; Attention; Behavior, Animal; Isoxazoles; Ligands; Lobeline; Mecamylamine; Nicotine; Pyrrolidines; Rats; Receptors, Nicotinic; Time Factors | 1995 |